Home
>
National Drug Code (NDC)
>
Tasigna
Tasigna - 0078-0526-51 - (nilotinib)
Drug Information of Tasigna
| Product NDC: | 0078-0526 |
| Proprietary Name: | Tasigna |
| Non Proprietary Name: | nilotinib |
| Active Ingredient(s): | 200 mg/1 & nbsp; nilotinib |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tasigna
| Product NDC: | 0078-0526 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022068 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20071029 |
Package Information of Tasigna
| Package NDC: | 0078-0526-51 |
| Package Description: | 28 CAPSULE in 1 BLISTER PACK (0078-0526-51) |
NDC Information of Tasigna
| NDC Code | 0078-0526-51 |
| Proprietary Name | Tasigna |
| Package Description | 28 CAPSULE in 1 BLISTER PACK (0078-0526-51) |
| Product NDC | 0078-0526 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nilotinib |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20071029 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | NILOTINIB |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
